FindTrial
Sign In

A medical records based study for prediction of hematoma enlargement in hypertensive intracerebral hemorrhage based on CT radiomics

Prediction of hematoma enlargement in hypertensive intracerebral hemorrhage based on CT radiomics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056196
Enrollment
Unknown
Registered
2022-02-01
Start date
2022-02-01
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertensive intracerebral hemorrhage

Interventions

Hematoma enlarged group vs. hematoma unenlarged group:None

Sponsors

Chongqing Emergency Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Accurate history of hypertension, defined as systolic blood pressure = 140mmHg and / or diastolic blood pressure >= 90mmHg; 2. The first CT scan was performed within 6 hours of onset; 3. Complete CT reexamination within 24 hours after onset.

Exclusion criteria

Exclusion criteria: 1. Secondary cerebral hemorrhage caused by brain injury, cerebrovascular malformation, aneurysm and tumor; 2. Ischemic cerebral infarction, hemorrhagic transformation; 3. Primary intraventricular hemorrhage; 4. Before CT Reexamination, he received surgical treatment such as hematoma removal or puncture and drainage; 5. CT image quality is poor and can not be accurately evaluated.

Design outcomes

Primary

MeasureTime frame
Hematoma volume;—

Countries

China

Contacts

Public ContactFei Yu

Chongqing Emeegency Medical Center(Chongqing University Central Hospital)

770217157@qq.com+86 13648346936

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026